Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes Care"
DOI: 10.2337/dc18-1091
Abstract: OBJECTIVE Healthy pancreatic β-cells secrete the hormones insulin and amylin in a fixed ratio. Both hormones are lacking in type 1 diabetes, and postprandial glucose control using insulin therapy alone is difficult. This study tested… read more here.
Keywords: insulin; fixed ratio; study; regular human ... See more keywords
Review: Rapid-acting analogues do not differ from regular human insulin for mortality or HbA1c in type 2 diabetes
Sign Up to like & getrecommendations! Published in 2019 at "Annals of Internal Medicine"
DOI: 10.7326/acpj201904160-039
Abstract: Question In patients with type 2 diabetes mellitus, what are the efficacy and safety of rapid-acting insulin analogues compared with regular human insulin (RHI)? Review scope Included studies compared rapid-acting insulin analogues (insulin lispro, insulin… read more here.
Keywords: insulin; type diabetes; rapid acting; mortality ... See more keywords